Trupanion, Inc. (NASDAQ:TRUP) Shares Sold by Connors Investor Services Inc.

Connors Investor Services Inc. reduced its holdings in Trupanion, Inc. (NASDAQ:TRUP) by 0.7% during the 4th quarter, Holdings Channel reports. The fund owned 76,415 shares of the financial services provider’s stock after selling 544 shares during the quarter. Connors Investor Services Inc.’s holdings in Trupanion were worth $3,683,000 as of its most recent filing with the Securities and Exchange Commission (SEC).

A number of other hedge funds and other institutional investors have also modified their holdings of TRUP. Baillie Gifford & Co. raised its stake in shares of Trupanion by 26.6% in the 4th quarter. Baillie Gifford & Co. now owns 701,366 shares of the financial services provider’s stock worth $33,806,000 after buying an additional 147,341 shares in the last quarter. First Trust Advisors LP acquired a new position in Trupanion during the fourth quarter worth about $7,083,000. Dimensional Fund Advisors LP raised its position in Trupanion by 112.2% in the fourth quarter. Dimensional Fund Advisors LP now owns 273,910 shares of the financial services provider’s stock worth $13,204,000 after acquiring an additional 144,828 shares in the last quarter. JPMorgan Chase & Co. lifted its holdings in Trupanion by 458.3% in the 4th quarter. JPMorgan Chase & Co. now owns 158,099 shares of the financial services provider’s stock valued at $7,620,000 after acquiring an additional 129,782 shares during the last quarter. Finally, Invesco Ltd. boosted its position in shares of Trupanion by 122.0% during the 4th quarter. Invesco Ltd. now owns 226,652 shares of the financial services provider’s stock valued at $10,925,000 after purchasing an additional 124,549 shares in the last quarter.

Analysts Set New Price Targets

Several brokerages recently issued reports on TRUP. Stifel Nicolaus reduced their price objective on Trupanion from $44.00 to $41.00 and set a “hold” rating for the company in a research note on Thursday, February 20th. Piper Sandler reduced their price target on shares of Trupanion from $57.00 to $52.00 and set an “overweight” rating for the company in a research report on Thursday, February 20th. Two equities research analysts have rated the stock with a hold rating, four have given a buy rating and one has issued a strong buy rating to the company’s stock. According to MarketBeat.com, the company currently has a consensus rating of “Moderate Buy” and an average price target of $46.60.

Insider Buying and Selling at Trupanion

In other Trupanion news, CEO Margaret Tooth sold 4,000 shares of the stock in a transaction on Monday, April 21st. The shares were sold at an average price of $33.34, for a total value of $133,360.00. Following the completion of the sale, the chief executive officer now directly owns 118,784 shares of the company’s stock, valued at $3,960,258.56. This represents a 3.26 % decrease in their position. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available at this link. Also, insider Brenna Mcgibney sold 5,000 shares of the company’s stock in a transaction dated Friday, March 7th. The shares were sold at an average price of $32.99, for a total transaction of $164,950.00. Following the transaction, the insider now directly owns 3,738 shares of the company’s stock, valued at $123,316.62. This represents a 57.22 % decrease in their position. The disclosure for this sale can be found here. Insiders have sold 33,792 shares of company stock valued at $1,122,802 in the last 90 days. 5.50% of the stock is currently owned by insiders.

Trupanion Price Performance

Shares of Trupanion stock opened at $37.82 on Wednesday. The company has a current ratio of 1.71, a quick ratio of 1.66 and a debt-to-equity ratio of 0.39. The firm has a fifty day simple moving average of $35.24 and a 200-day simple moving average of $45.13. The stock has a market capitalization of $1.61 billion, a price-to-earnings ratio of -164.43, a PEG ratio of 6.02 and a beta of 1.66. Trupanion, Inc. has a 1-year low of $19.69 and a 1-year high of $57.90.

Trupanion (NASDAQ:TRUP) last released its earnings results on Wednesday, February 19th. The financial services provider reported $0.04 earnings per share for the quarter, missing analysts’ consensus estimates of $0.06 by ($0.02). The firm had revenue of $337.31 million for the quarter, compared to analyst estimates of $335.41 million. Trupanion had a negative return on equity of 3.08% and a negative net margin of 0.75%. On average, sell-side analysts expect that Trupanion, Inc. will post 0.13 earnings per share for the current year.

Trupanion Profile

Trupanion, Inc, together with its subsidiaries, provides medical insurance for cats and dogs on a monthly subscription basis in the United States, Canada, Continental Europe, and Australia. The company operates in two segments, Subscription Business and Other Business. It serves pet owners and veterinarians.